Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Dec;38(12):2269-81.
doi: 10.1007/s00259-011-1904-z. Epub 2011 Aug 30.

Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - a review

Uta Eberlein  1 , Jörn Hendrik Bröer, Charlot Vandevoorde, Paula Santos, Manuel Bardiès, Klaus Bacher, Dietmar Nosske, Michael Lassmann
Affiliations
Review

Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - a review

Uta Eberlein et al. Eur J Nucl Med Mol Imaging. 2011 Dec.

Abstract

Purpose: The impact on patients' health of radiopharmaceuticals in nuclear medicine diagnostics has not until now been evaluated systematically in a European context. Therefore, as part of the EU-funded Project PEDDOSE.NET ( www.peddose.net ), we review and summarize the current knowledge on biokinetics and dosimetry of commonly used diagnostic radiopharmaceuticals.

Methods: A detailed literature search on published biokinetic and dosimetric data was performed mostly via PubMed ( www.ncbi.nlm.nih.gov/pubmed ). In principle the criteria for inclusion of data followed the EANM Dosimetry Committee guidance document on good clinical reporting.

Results: Data on dosimetry and biokinetics can be difficult to find, are scattered in various journals and, especially in paediatric nuclear medicine, are very scarce. The data collection and calculation methods vary with respect to the time-points, bladder voiding, dose assessment after the last data point and the way the effective dose was calculated. In many studies the number of subjects included for obtaining biokinetic and dosimetry data was fewer than ten, and some of the biokinetic data were acquired more than 20 years ago.

Conclusion: It would be of interest to generate new data on biokinetics and dosimetry in diagnostic nuclear medicine using state-of-the-art equipment and more uniform dosimetry protocols. For easier public access to dosimetry data for diagnostic radiopharmaceuticals, a database containing these data should be created and maintained.

PubMed Disclaimer

References

    1. ICRP. Publication 53: Radiation dose to patients from radiopharmaceuticals. Ann ICRP. 1987;18(1–4). - PubMed
    1. ICRP. Publication 80: Radiation dose to patients from radiopharmaceuticals: Addendum 2 to ICRP publication 53. Ann ICRP. 1998;28 (3). - PubMed
    1. ICRP. Publication 106: Radiation dose to patients from radiopharmaceuticals: Addendum 3 to ICRP Publication 53. Ann ICRP. 2008;38 (1–2). - PubMed
    1. Lassmann M, Chiesa C, Flux G, Bardiès M. EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting. Eur J Nucl Med Mol Imaging. 2011;38(1):192–200. - PubMed
    1. Bolch WE, Eckerman KF, Sgouros G, Thomas SR. MIRD Pamphlet No. 21: A generalized schema for radiopharmaceutical dosimetry – standardization of nomenclature. J Nucl Med. 2009;50(3):477–484. - PubMed

Publication types

Substances